This section is still in development. Where an MS-Selfie summary is not yet available, links to the manufacturers’ patient information leaflets are provided.
Alemtuzumab
(Lemtrada)
Anti-CD20s (ocrelizumab, ofatumumab, ublituximab) – details to follow
Cladribine
(Mavenclad)
Fumarates (dimethyl fumarate and diroximel fumarate)
(Tecfidera, Vumerity)
Glatiramer acetate (GA)
(Copaxone, Brabio)
HSCT/AHSCT
(Haematopoietic stem cell transplant/autologous haematopoietic stem cell transplant)
Interferon-beta (IFN-beta)
(Avonex, Betaferon, Betaseron, Extavia, Plegridy, Rebif)
Mitoxantrone
(Novantrone)
Natalizumab
(Tysabri)
Sphingosine 1-phosphate (S1P) modulators (fingolimod, siponimod, ozanimod, ponesimod)
(Gilenya, Mayzent, Zeposia, Ponvory)
Teriflunomide
(Aubagio)